ClinicalTrials.gg
RecruitingNCT07475013GPNMB-PERIO StUpdated Nov 17, 2026

Effects of Non-Surgical Periodontal Treatment on Inflammatory and Bone Markers in Periodontitis Patients

An interventional study of Scaling and Root Planing (SRP) in Periodontitis (Stage 3), sponsored by Saglik Bilimleri Universitesi. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Saglik Bilimleri Universitesi · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Updated Nov 17, 2026Now RecruitingSite recruiting status changed+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Non-randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 16 studies in Periodontitis by Saglik Bilimleri Universitesi — 6 open to participants now, 7 under way, none of them phase 3. Periodontitis · Saglik Bilimleri Universitesi.

Started
2026
with 5 others
No phase
7 of 16
4 open now
Registered
13th of 16
by date

Among the 16 studies in Periodontitis by Saglik Bilimleri Universitesi, this one is one of 6 that started in 2026, is one of 7 with no phase, and was the 13th registered.

Periodontitis

1,242 studies on the registry are indexed under Periodontitis; 304 are open to participants now.

Browse Periodontitis studies →

Open to participants now

6 of the 16 studies in Periodontitis by Saglik Bilimleri Universitesi are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 163 Periodontitis studies recruiting now, 80 (49%) set no upper age limit and 62 (38%) stop at 75 or younger; 12 take children under 18; 80 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Periodontitis by Saglik Bilimleri Universitesi, or all of them as a file.
02

Study summary

The goal of this study is to learn how a standard treatment called Scaling and Root Planing (SRP) affects specific biochemical markers in people with advanced gum disease (periodontitis). Periodontitis is a chronic condition that can lead to tooth loss.

The main focus is to investigate a marker called Glycoprotein Non-Metastatic B (GPNMB). This is the first study to examine GPNMB levels in both the serum and the gingival crevicular fluid of people with this condition. The study aims to answer these main questions:

How do GPNMB levels change after the Scaling and Root Planing treatment?

How does GPNMB relate to other markers that control bone health and healing, such as TGF-β1, RANKL, and Osteoprotegerin?

Researchers will compare 28 participants with advanced gum disease (Stage III Grade B/C) to 28 participants with healthy gums to see how these markers differ.

Participants in the gum disease group will:

Provide samples for laboratory analysis at the start of the study.

Receive the standard mechanical treatment of their teeth and roots (Scaling and Root Planing).

Return for follow-up visits 6 weeks and 3 months after treatment to provide new samples and have their gum health checked.

03

Conditions studied

  • Periodontitis (Stage 3)

Browse trials for

Keywords

  • TGF-beta1
  • GPNMB
  • RANKL
  • OPG
  • Periodontitis
  • non-surgical periodontal treatment
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Systemically healthy individuals
  • Individuals diagnosed with Stage III Grade B or Grade C periodontitis (for the periodontitis group)
  • Periodontally healthy individuals (for the healthy control group)
  • Participants aged 18 years and older

Exclusion criteria

Exclusion Criteria:

  • Individuals who have received periodontal treatment within the last 6 months
  • Individuals who have used antibacterial drugs within the last 6 months
  • Individuals with any systemic disease
  • Individuals who use medications on a regular basis
  • Current smokers
  • Pregnant individuals
  • Participants under the age of 18 years
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Periodontitis Group

    Participants with Stage III Grade B/C periodontitis. At baseline, clinical periodontal measurements are recorded, and serum and gingival crevicular fluid samples are collected. All participants receive non-surgical periodontal therapy consisting of Scaling and Root Planing (SRP). Follow-up visits are conducted at 6 weeks and 3 months post-treatment for repeated clinical assessments and sample collection to evaluate changes in biochemical markers (GPNMB, TGF-β1, RANKL, and OPG).

    Procedure: Scaling and Root Planing (SRP)

  • No intervention
    Healthy Control Group

    Periodontally healthy individuals. Participants undergo a single clinical periodontal examination and provide serum and gingival crevicular fluid samples at the baseline visit. This group serves as a reference for baseline biochemical marker levels. No therapeutic intervention is performed.

Interventions

  • ProcedureScaling and Root Planing (SRP)

    A standard non-surgical mechanical treatment that involves the removal of plaque and calculus from the teeth and root surfaces using ultrasonic devices and hand instruments.

06

What researchers measure

Primary outcomes

  1. Change in Gingival Crevicular Fluid (GCF) Glycoprotein Non-Metastatic B (GPNMB) Concentration

    Concentration of GPNMB in gingival crevicular fluid samples measured by Enzyme-Linked Immunosorbent Assay (ELISA). Results will be expressed in picograms per microliter (pg/µL) to evaluate the local biochemical response following scaling and root planing (SRP).

    Time frame: Baseline, 6 weeks, and 3 months post-treatment.

  2. Change in Serum Glycoprotein Non-Metastatic B (GPNMB) Concentration

    Concentration of GPNMB in serum samples measured by Enzyme-Linked Immunosorbent Assay (ELISA) to evaluate the systemic biochemical response. The results will be quantified and reported in picograms per milliliter (pg/mL) to evaluate the change in mean concentration values across the specified measurement intervals.

    Time frame: Baseline, 6 weeks post-treatment, and 3 months post-treatment.

  3. Change in Gingival Crevicular Fluid (GCF) Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Concentration

    Concentration of RANKL in gingival crevicular fluid samples measured via ELISA to assess local bone resorption activity. The data will be quantified in picograms per microliter (pg/µL) at baseline and post-treatment intervals.

    Time frame: Baseline (before treatment), 6 weeks post-treatment, and 3 months post-treatment.

  4. Change in Serum Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) Concentration

    Concentration of RANKL in serum samples measured by ELISA to evaluate the systemic bone resorption activity. The results will be quantified and reported in picograms per milliliter (pg/mL) to evaluate the change in mean concentration values across the specified measurement intervals following periodontal therapy.

    Time frame: Baseline (before treatment), 6 weeks post-treatment, and 3 months post-treatment.

  5. Change in Gingival Crevicular Fluid (GCF) Osteoprotegerin (OPG) Concentration

    Concentration of OPG in gingival crevicular fluid samples measured by ELISA to assess the local bone-protective response. The results will be quantified and reported in picograms per microliter (pg/µL) to evaluate the change in mean concentration values across the specified measurement intervals following scaling and root planing (SRP).

    Time frame: Baseline (before treatment), 6 weeks post-treatment, and 3 months post-treatment.

  6. Change in Serum Osteoprotegerin (OPG) Concentration

    Concentration of OPG in serum samples measured by ELISA to evaluate the systemic bone-protective response. Measurement values will be reported in picograms per milliliter (pg/mL) to compare the changes in mean concentration values across the specified measurement intervals following periodontal therapy.

    Time frame: Baseline (before treatment), 6 weeks post-treatment, and 3 months post-treatment.

  7. Change in Gingival Crevicular Fluid (GCF) Transforming Growth Factor beta 1 (TGF-β1) Concentration

    Concentration of TGF-β1 in gingival crevicular fluid samples measured by Enzyme-Linked Immunosorbent Assay (ELISA). This analysis evaluates the local anti-inflammatory response and tissue healing following scaling and root planing (SRP). The results will be quantified and reported in picograms per microliter (pg/µL) to evaluate the change in mean concentration values across the specified measurement intervals.

    Time frame: Baseline (before treatment), 6 weeks post-treatment, and 3 months post-treatment.

  8. Change in Serum Transforming Growth Factor beta 1 (TGF-β1) Concentration

    Concentration of TGF-β1 in serum samples measured by ELISA to evaluate the systemic anti-inflammatory response. Measurement values will be reported in picograms per milliliter (pg/mL) to compare the changes before and after scaling and root planing (SRP).

    Time frame: Baseline (before treatment), 6 weeks post-treatment, and 3 months post-treatment.

Secondary outcomes

  1. Change in Probing Pocket Depth (PPD)

    Probing Pocket Depth (PPD) will be measured at six sites per tooth using a Williams periodontal probe to evaluate the depth of the periodontal pockets.

    Time frame: Baseline (before treatment), 6 weeks post-treatment, and 3 months post-treatment.

  2. Change in Clinical Attachment Loss (CAL)

    Clinical Attachment Loss (CAL) will be measured at six sites per tooth using a Williams periodontal probe to assess the level of periodontal tissue attachment.

    Time frame: Baseline (before treatment), 6 weeks post-treatment, and 3 months post-treatment.

  3. Change in Plaque Index (PI)

    Plaque Index (PI) will be used to assess the amount of plaque on the tooth surfaces to evaluate oral hygiene status.

    Time frame: Baseline (before treatment), 6 weeks post-treatment, and 3 months post-treatment.

  4. Change in Gingival Index (GI)

    Gingival Index (GI) will be used to assess the severity of gingival inflammation based on color, consistency, and bleeding tendency.

    Time frame: Baseline (before treatment), 6 weeks post-treatment, and 3 months post-treatment.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2026 (actual). Primary completion is estimated for Feb 2027, 10 months after the start.

Of 484 non-industry interventional studies with no phase under Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 31. This study's planned 10 months is below that.

Counting every sponsor, half of 498 studies reached it within 15 months; a quarter within 8 and three quarters within 31.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 17, 2026: primary completion Sep 2026 → Feb 2027 and completion Dec 2026 → Apr 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2026
First posted
Mar 16, 2026
StartActual
Mar 15, 2026
Primary completionEst.
Feb 1, 2027was Sep 2026
CompletionEst.
Apr 1, 2027was Dec 2026
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Recruiting
changed Nov 17, 2026
Sites
Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği Fakültesi is now Recruiting
Nov 17, 2026
Primary completion
Sep 1, 2026→Feb 1, 2027
Nov 17, 2026
Study completion
Dec 1, 2026→Apr 1, 2027
Nov 17, 2026
Contact
Study contact now listed: added o•••@sbu.edu.tr · •••6482; added e•••@sbu.edu.tr · •••9924. See the current contact
Nov 17, 2026
Site contacts
Changed at 1 site. See the sites
Show the site
  • Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği Fakültesi · Ankara, Turkey (Türkiye)Contact added o•••@hotmail.com · •••6482Contact added e•••@gmail.com · •••9924
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    Active, not recruiting→Recruiting
    Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği Fakültesi is now Recruiting
    Primary completion Sep 1, 2026→Feb 1, 2027
    Study completion Dec 1, 2026→Apr 1, 2027
    Contact Study contact now listed: added o•••@sbu.edu.tr · •••6482; added e•••@sbu.edu.tr · •••9924. See the current contact
    Site contacts Changed at 1 site. See the sites
    Show the site
    • Sağlık Bilimleri Üniversitesi Gülhane Diş Hekimliği Fakültesi · Ankara, Turkey (Türkiye)Contact added o•••@hotmail.com · •••6482Contact added e•••@gmail.com · •••9924
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07475013
Responsible party
Özlem SARAÇ ATAGÜN (Associate Professor, Saglik Bilimleri Universitesi) — Principal investigator
First posted
Mar 16, 2026
Start date
Mar 15, 2026
Primary completion
Feb 1, 2027 (estimated)
Completion
Apr 1, 2027 (estimated)
Last update
Nov 17, 2026

Study contacts

Özlem Saraç Atagün
Contact
ozlem.saracatagun@sbu.edu.tr
+90 5055096482
Elif Toprak
Contact
elif.toprak@sbu.edu.tr
+90 5059909924

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion